ANTION BIOSCIENCES
Antion Biosciences SA is a cell and gene engineering biotechnology company based in Geneva (Switzerland). It develops off-the-shelf therapies for the treatment of diseases with significant unmet medical needs. Antion’s proprietary technology allows for a modular and tunable approach to multiplex engineering of therapeutic cells. We have made a strategic shift to re-purpose our miCAR19 developments for autoimmune disease, building upon the recently shown in vivo proof-of-concept data with our... lead product, miCAR7. Antion is one of the few players with an allogeneic solution. By leveraging its multiplex engineering technology, it has the potential to deliver a best-in-class product for B-cell-driven autoimmune disease. Significant preclinical progress has already been made, with the following value inflection point being proof-of-concept in humans.
ANTION BIOSCIENCES
Social Links:
Industry:
Biotechnology Medical
Founded:
2016-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.antionbio.com
Total Employee:
11+
Status:
Active
Contact:
+41 (0)22 310 63 70
Total Funding:
7.11 M USD
Technology used in webpage:
SPF IPv6 Microsoft Exchange Online Office 365 Mail Infomaniak Network
Similar Organizations
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
ExpressCells
ExpressCells creates custom cell lines for biological research and drug discovery.
Invisible Sentinel
At Invisible Sentinel, we develop first in class, next generation technologies for a safer food supply.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
FONGIT
FONGIT investment in Debt Financing - Antion Biosciences
Allogene Therapeutics
Allogene Therapeutics investment in Corporate Round - Antion Biosciences
Allogene Therapeutics
Allogene Therapeutics investment in Corporate Round - Antion Biosciences
Official Site Inspections
http://www.antionbio.com Semrush global rank: 8.5 M Semrush visits lastest month: 523
- Host name: h2web210.infomaniak.ch
- IP address: 128.65.195.230
- Location: Satigny Switzerland
- Latitude: 46.2146
- Longitude: 6.0355
- Timezone: Europe/Zurich
- Postal: 1242
More informations about "Antion Biosciences"
Antion Biosciences
Antion has developed a propietary gene engineering technology with unmatched versatility to overcome key challenges facing cell and gene therapySee details»
Antion Biosciences - Crunchbase Company Profile
Organization. Antion Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Antion Biosciences SA – Swiss Biotech
Antion is at the forefront of cell and gene therapy innovation, with a groundbreaking platform that enables simultaneous gene expression and silencing. It's multiplex engineering technology is …See details»
Antion Biosciences SA - LinkedIn
Antion Biosciences SA (Antion) is a Swiss biopharmaceutical company developing novel gene and gene-modified cell therapies to treat and cure diseases with significant unmet medical needs.See details»
Antion Biosciences SA Overview | SignalHire Company Profile
Organization Website. antionbio.com . Antion Biosciences SA industries. Biotech Headquarters Location. Chemin des Aulx 12, CTN12, Plan-les-Ouates, Canton of Geneva, 1228 CH. Antion …See details»
20230725_New_Chairman_and_Board - antionbio.com
Jul 25, 2023 [email protected] Antion Biosciences SA Chemin des Aulx 12, CTN12 1228 Plan-les-Ouates Switzerland . Title: 20230725_New_Chairman_and_Board Author: Sten …See details»
Antion Biosciences - PitchBook
Information on valuation, funding, acquisitions, investors, and executives for Antion Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Antion Biosciences S.A. - VentureRadar
Website: https://antionbio.com. Develops universally accessible cell and gene therapies using a proprietary platform for safe, efficient, and cost-effective treatment outcomes. Bio€quity …See details»
Antion Biosciences SA - startup.ch
Antion Biosciences SA: Antion Biosciences SA is a cell and gene engineering biotechnology company based in Geneva (Switzerland), developing allogeneic immune cell therapies for the treatment of diseases with significant unmet …See details»
Antion Biosciences SA - BioAlps
Avenue de Sécheron 15 1202 Geneva, Switzerland T +41 22 545 12 91. c/o BIOPÔLE SA Secteur Esplanade / Bâtiment Serine Route de la Corniche 8 1066 Epalinges, SwitzerlandSee details»
Antion Biosciences at the Swiss Biotech Day
Antion Biosciences is a cell and gene therapy company developing off-the-shelf products for the treatment and cure of diseases with significant unmet medical needs.See details»
Antion Biosciences - Products, Competitors, Financials, Employees ...
Antion’s proprietary technology platform allows for a modular and tunable approach to multiplex engineering of therapeutic cells. Through development of off-the-shelf and immune privileged …See details»
Antion Biosciences S.A. - VentureRadar
Website: https://antionbio.com. ... Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for …See details»
Antion Welcomes John Tchelingerian as hairman of the oard
Https://www.antionbio.com. Antion's autionary Note on Forward-Looking Statements Please note: This announcement can contain forward-looking statements based on current expectations …See details»
Antion Announces Granting of Key Technology Patent in the …
Sep 6, 2023 information, please visit https://www.antionbio.com. Antion's autionary Note on Forward-Looking Statements Please note: This announcement can contain forward-looking …See details»
Antion Biosciences Announces Presentation of Two Abstracts
Oct 17, 2023 [email protected] Antion Biosciences SA Chemin des Aulx 12, CTN12 1228 Plan-les-Ouates Geneva Switzerland. TagsSee details»
Antion Biosciences announces development of safety-enhanced …
May 22, 2024 Autoimmunity affects up to 10% of the global population, and the overall burden of care is believed to well-exceed US $120 billion per annum. Recent findings indicate that …See details»
Antion iosciences announces latest data and validation of its ...
Mar 6, 2024 https://www.antionbio.com. Antion's autionary Note on Forward-Looking Statements Please note: This announcement can contain forward-looking statements based on current …See details»
Antion Biosciences Announces Presentation of Two Abstracts from …
GENEVA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is delighted to announce the presentation of …See details»
Antion iosciences announces development of safety-enhanced …
May 22, 2024 patients. For more information, please visit https://www.antionbio.com. Antion's autionary Note on Forward-Looking Statements Please note: This announcement can contain …See details»